glp1 retatrutide vs Semaglutide and Tirzepatide: GLP-3 Facts explained Retatrutide 10mg & 20mg Research

For mechanistic comparison with single and dual agonists, see our GLP-1 metabolic research guide

In Vivo

Study overview: Researchers from Alliance Medical (Europe) analyzed oncologic PET-CT scans in patients receiving GLP-1 therapy and observed abnormal fluorodeoxyglucose (FDG) uptake patterns that could easily be mistaken for pathological hot spots. In some cases, what appears to be malignant metabolic activity may, in fact, represent drug-induced metabolic redistributionlikely linked to delayed gastric emptying and altered glucose metabolism caused by GLP-1 agonism

Im extremely nervous about whats going to happen, he says